Ziopharm Oncology, Inc.

NASDAQ:ZIOP

1.23

-0.09 (-6.82%)

4:40:12 PM EDT: $1.25 +0.02 (+1.63%)

Ziopharm Oncology, Inc. Stock, NASDAQ:ZIOP

Navy Yard Plaza, 1 First Avenue, Boston, Massachusetts 02129

United States of America

Phone: +1.617.259.1970

Number of Employees: 106

http://www.ziopharm.com

Description

ZIOPHARM Oncology, Inc. is a biopharmaceutical company, which engages in the development, acquisition, and commercialization of immuno-oncology platforms that leverage cell- and gene-based therapies to treat patients with cancer. Its pipeline includes Sleeping Beauty TCR-T Targeting neoantigens; Ad-RTS-hlL-12 + veledimex; and Sleeping Beauty CAR-T. The company was founded on September 9, 2003 and is headquartered in Boston, MA.